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AbstrAct
Objective A National Health Service (NHS)- funded sore 
throat test and treat (STTT) service was introduced in 
selected pharmacies in two local health boards in Wales, 
as an extension to the national pharmacy common ailment 
scheme. The aim of this study was to evaluate the impact 
of STTT on provision and quality of patient care, namely 
antibiotic use, patient safety and general practitioner (GP) 
consultation rates.
Methods Secondary analyses of STTT consultation data 
to describe service outcomes, and routine data to explore 
changes in antibiotic prescribing and the prevalence of 
complications. Data were also collected from one GP 
practice to explore the feasibility of measuring changes in 
sore throat consultation rates in general practice.
Results Less than 20% of 1725 consultations resulted 
in antibiotic supply. The availability of STTT was 
associated with greater reductions in prescriptions for 
phenoxymethylpenicillin than in areas where STTT was 
not available (−3.8% and −3.4%, difference 0.4%). When 
pharmacy supplies were included, the reductions in the 
supply of the antibiotic were similar. No increase in the 
monthly number of incidents of quinsy was detected, and 
patients were appropriately referred to other healthcare 
professionals during pharmacy consultations. GP 
consultation rates since introduction of STTT were found to 
be lower than the equivalent monthly average since 2014.
Conclusions Data from the first 5 months of the 
STTT service suggest that it may have a role in safely 
rebalancing uncomplicated sore throat management 
from general practice to community pharmacies while 
continuing to promote antibiotic stewardship.
InTroducTIon
Sore throat is a condition that frequently 
presents to primary care. An average- sized UK 
general practice with a list size of 7000, has 
an estimated 5481 consultations with 3562 
antibiotic prescriptions for sore throat over 
10 years.1 Around 60%–78% of sore throat 
consultations result in an antibiotic prescrip-
tion.2 However, most sore throats are caused 
by a virus and around 80% of people recover 
without any treatment within 8 days.3 Some 
sore throats may be caused by bacteria, most 
commonly, group A beta- haemolytic strepto-
coccus (GABHS), and antibiotic prescribing 
where GABHS is suspected is partly driven by 
a desire to prevent suppurative complications 
such as peritonsillar abscess (quinsy).4 5 Distin-
guishing between viral and bacterial infec-
tions is difficult because the signs and symp-
toms are similar regardless of cause, and this 
can lead to unnecessary antibiotic prescribing 
which contributes to the global public health 
issue of antimicrobial resistance (AMR).6 
Throat swabs can help guide prescribing 
but delays in bacteriology results limit their 
use in general practice meaning they are 
not recommended for routine use.7 Rapid 
antigen detection testing (RADT) has a spec-
ificity of greater than 95% and sensitivity of 
70%–90% for GABHS. Given its high speci-
ficity and limited sensitivity, a positive RADT 
can be useful in establishing the presence of 
GABHS,8 although in its most recent diag-
nostic guideline on rapid antigen tests for 
GABHS infection in people with sore throat, 
the National Institute for Health and Care 
Excellence (NICE) concluded that the use 
of RADT by general practitioners (GPs) was 
unlikely to be a cost- effective use of National 
Health Service (NHS) resources when added 
to clinical assessment by GPs.9
In Wales, patients with sore throat are 
encouraged to seek advice from community 
pharmacies through the national pharmacy 
common ailment service (CAS). Only symp-
tomatic treatments (eg, analgesics) are avail-
able from pharmacies providing CAS and no 
antibiotics can be supplied, meaning that 
many patients still prefer to see a GP.10 In 
November 2018, the CAS service was extended 
in selected pharmacies to incorporate RADT 
in sore throat consultations with antibiotic 
supply if prespecified clinical criteria were 
met,11 as defined in the sore throat test and 
treat (STTT) service. The STTT service had 
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several aims; (1) To provide a more accessible, efficient 
and high- quality clinical pathway for patients with a sore 
throat. (2) To better use pharmacist skills and free up GP 
time for more complex and urgent medical issues. (3) 
To more accurately screen for GABHS and potentially 
reduce unnecessary antibiotic prescribing.
A previous study found that it is feasible to deliver a 
community- pharmacy- based screening and treatment 
service using RADT,12 but no conclusive evidence could 
be provided on effectiveness or cost- effectiveness.13 14 
Additionally, the previous study looked only at provision 
of a private, commercial service in which patients were 
required to pay for investigation and treatment. It is not 
known whether the results of that study would be repro-
duced in the NHS. The wider available evidence on RADT 
for sore throats is inconclusive. While randomised trials 
have suggested no additional benefit over clinical scores 
alone11 15 and the recent NICE guideline did not recom-
mend RADT use,9 it is recognised there is a lack of robust 
evidence regarding the role of RADT in community phar-
macies and its value in this setting is still unknown. NICE 
has recommended further research to measure the wider 
effects of RADT on public health and antimicrobial stew-
ardship in healthcare settings other than general practice.
The implementation of STTT provided a unique 
opportunity to evaluate such a service, in the NHS and 
in a real- world setting. While trials are a vital part of eval-
uating new diagnostic pathways, it is important to under-
stand the role of the STTT service in a health system 
where patients make their own choices as to how and 
when to access treatment, which precluded a prospective 
randomised trial. This study aimed to evaluate whether a 
pharmacy- led STTT service had an impact on antibiotic 
use, patient safety, and GP consultation rates.
PaTIenTs and meThods
sTTT pilot service
The STTT service was available in 56 community pharma-
cies in two local health boards (LHBs) in Wales, in estab-
lished CAS sites whereby CAS had been embedded in 
primary care pathway for more than 6 months. Initially 23 
pharmacies in an LHB in central South Wales commenced 
the service in November 2018. The service was extended 
to another 33 pharmacies in an LHB in North Wales 
by December 2018. Pharmacy sites were commissioned 
within the LHBs based on a balance of population needs 
and expressions of interest from pharmacy sites that had 
already been offering CAS for a minimum of 6 months.
The STTT service specification (a document describing 
the conditions under which commissioned community 
pharmacies were required to provide the service including 
any training requirements, and clinical inclusion and 
exclusion criteria) was developed collaboratively by the 
LHBs who determined all children under 6 years would 
be excluded and referred to their GP (online supplemen-
tary figure 1). Patients aged 6 years and over presenting 
with acute sore throat at a participating pharmacy were 
assessed using either FeverPAIN or CENTOR clinical 
scoring, validated methods to support identification of 
bacterial infection.16 The choice of scoring method was 
left to the pharmacist’s discretion. Pharmacists received 
detailed training on throat examination, use of scoring 
tools and sampling using a throat swab. Patients with 
FeverPAIN >3 or CENTOR>2 were offered RADT in the 
pharmacy, allowing pharmacists to quickly ascertain pres-
ence of GABHS. Clinical scoring allows targeted testing of 
those most likely to have a GABHS infection rather than 
asymptomatic GABHS carriers. Patients with a positive 
test were offered antibiotics supplied by the pharmacist 
under a Patient Group Direction.11 Leaflets promoting 
self- care and providing information about the effective-
ness of antibiotic use for sore throats were developed by 
the Welsh Medicines Information Service, approved by 
the all Wales Medicines Strategy Group and used in the 
service.17 Pharmacists were asked to make a follow- up tele-
phone consultation for all patients accessing the STTT 
service within 10–14 days of each consultation. This was 
used to assess treatment success and subsequent health 
service utilisation (eg, appointments with a GP).
study design
This study involved secondary analyses of data obtained 
from routine data sources. Data were analysed using 
Microsoft Excel, IBM SPSS V.23 to obtain descriptive 
statistics and Stata Statistical Software release V.16 to 
undertake more detailed statistical comparisons.
data collection
Service outcomes
Data from all STTT consultations were collected between 
November 2018 (service introduction) and end of March 
2019, to describe service outcomes. Data were obtained 
through the Choose Pharmacy system, an IT application 
supporting delivery of services through community phar-
macies in Wales. Data included standardised demographic 
information derived from matching patients to existing 
health records in the Welsh Demographic Service, and 
clinical information in the form of free- text and prede-
fined responses recorded by pharmacists during consul-
tations and follow- up telephone calls.
Patient safety
There is currently no routine data linkage of pharmacy 
data to other primary or secondary care data that would 
enable us to track patients who have visited pharmacies 
for STTT. To explore possible impact on patient safety, 
hospital admissions for quinsy were monitored, as a surro-
gate for possible complication of untreated GABHS infec-
tions. Patient Episode Database for Wales data for coded 
hospital inpatient stays of quinsy were obtained from the 
NHS Wales Informatics Service (NWIS) for the period 
March 2014 to March 2019.18 Data for a period of 4 full 
years prior to the service’s introduction were obtained to 
account for seasonal variation that may have impacted on 
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quinsy hospital admissions, and would allow us to calcu-
late averages and 95% CIs.
In addition, free- text comments providing clinical 
information recorded by pharmacists during consulta-
tions were analysed using content and deductive thematic 
analysis for patients who were referred to another health-
care professional, to explore appropriateness of referrals. 
Data were also analysed for patients who were followed 
up, to explore possible patient deterioration after an 
STTT consultation. The number of patients who had 
further contact with healthcare professionals was calcu-
lated and pharmacist comments in relation to patient- 
reported reasons for seeking further advice were analysed 
thematically.
GP consultations
Data were also obtained from one GP practice to explore 
the feasibility of measuring changes in sore throat consul-
tation rates in general practice pre and post STTT service 
implementation. Audit+ was used as a data source to 
extract Read- coded GP sore throat related consultations 
for full 4 years prior to STTT, between March 2014 to 
March 2019.19 The GP practice selected (list size=10 220) 
was located adjacent to four community pharmacies in 
which the STTT service was available (online supplemen-
tary table 1).
Antibiotic prescribing
Comparison of antibiotic prescribing was completed 
using an ecological study design which analysed data at 
the population rather than individual level to identify any 
association in total antibiotic supply between interven-
tion (STTT) and non- intervention (non- STTT) areas.20 
This design has been used previously to explore the 
impact of licensing changes on antibiotic (chloramphen-
icol) supply rates. This approach relied on a linear regres-
sion model to predict the number of antibiotic prescrip-
tions at the end of the study period. We determined that 
in order to make the regression model robust it would 
be necessary to obtain data for 25 months prior to the 
intervention. This was in line with previous studies.21 
Data were provided by the NHS Wales Shared Services 
Partnership (NWSSP). Monthly antibiotic prescribing 
data for the period October 2016 to March 2019 were 
provided for each primary care cluster, that is, a group of 
GP practices serving populations of between 50 000 and 
100 000 people, within the two LHBs in which the STTT 
service was available. Clusters were designated as STTT 
and non- STTT depending on whether or not community 
pharmacies within their respective areas were providing 
the STTT service (online supplementary table 2). A retro-
spective analysis of prescription and pharmacy supply 
data for phenoxymethylpenicillin in areas in which STTT 
was available was undertaken. Phenoxymethylpenicillin 
prescriptions, the recommended antibiotic treatment 
for sore throat,22 were chosen for analysis. Phenoxyme-
thylpenicillin is not indicated for treatment of any other 
acute bacterial infection in Wales and as such was assumed 
to be a good measure of antibiotic prescribing for sore 
throat. Prescriptions for second line antibiotics (clarithro-
mycin and erythromycin) were excluded because they 
were only indicated for patients with a known penicillin 
allergy and had multiple possible indications. Prescribing 
data for non- STTT clusters were used as a control.
Linear regression was used to generate a cumulative 
supply equation for phenoxymethylpenicillin prescrip-
tions (r=0.999, p<0.005) and predict the number of 
supplies (ie, prescriptions and pharmacy supplies) of 
phenoxymethylpenicillin in STTT clusters at month 30 
of the study. The regression model was used to predict 
prescription numbers at month 30, and was based on 
NWSSP prescription data for the 25 months immediately 
preceding the availability of the STTT service (month 1: 
October 2016). Similar linear regression models were used 
to predict the number of prescriptions for phenoxymeth-
ylpenicillin in non- STTT clusters (r=0.999, p<0.005) and 
for oral broad- spectrum penicillins (as an indicator of the 
general trend in antibiotic prescribing within STTT clus-
ters) in STTT clusters (r=0.999, p<0.005). The effect of 
STTT on antibiotic supplies was estimated using a differ-
ence in difference design comparing phenoxymethyl-
penicillin supplies in STTT and non- STTT clusters, and 
phenoxymethylpenicillin and broad- spectrum antibiotic 
prescriptions within STTT clusters.
ethical considerations
The study was registered with the Research and Develop-
ment department of both LHBs. There were no identi-
fiers that could link information to an individual in any 
of the data sets; as such, this study required no ethical 
approval. The process for obtaining and using Audit+ 
GP data was approved by the NWIS Data Quality System 
Governance Board.
Patient involvement
Two members of the Lay Faculty of Cardiff School of 
Pharmacy and Pharmaceutical Sciences provided patient 
insight throughout the conceptualisation of the eval-
uation of the service. Patients were not involved in the 
design or conduct of this arm of the study.
resulTs
During the study period 1725 STTT consultations were 
undertaken in the 56 participating community pharma-
cies. Table 1 summarises the characteristics of service 
users, patient alternative action had the service not been 
available, referral sources to STTT and use of clinical 
scoring tools during consultations.
Of the 1725 patients screened using FeverPAIN 
or CENTOR, 1239 patients were found to meet the 
threshold criteria for RADT (72%). Of the 1239 patients 
having the RADT test, a total of 350 (28.2%) tested posi-
tive for GABHS and 340 ((27.4%) were supplied antibi-
otics. Ten patients did not receive antibiotics, four were 
referred to their GPs due to feeling systemically unwell or 
because of a recent recurrent infection and six patients 
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Table 1 Descriptive overview of the sore throat test and treat (STTT) service consultations
Patients 
(n=1725)
Patients followed 
up at 10–14 days 
(n=537)
Patients not followed- 
up
(n=1188)
Patient demographics
Age at consultation (years) Median 29.2 28.8 29.4
IQR 16–39 15–38 16–39
Range (SD) 6–89 (17.4) 6–79 (17.1) 6–89 (17.5)
Gender
(% of total population)
Male 582 (33.7%) 185 (34.5%) 397 (33.4%)
Female 1143 (66.3%) 352 (65.4%) 791 (66.6%)
Factors related to engagement with STTT
Referred to the pharmacy 
by:
(% of total population)
General practitioner 991 (57.4%) 300 (55.9%) 691 (58.2%)
Self- referral 667 (38.7%) 218 (40.6%) 449 (37.8%)
Other (OOH/other HCP/ NHS 111/
NHS Direct)
48 (2.8%) 15 (2.8%) 33 (2.8%)
Missing values   19 (1.1%) 4 (0.7%) 15 (1.3%)
What would the patient 
have done if the service 
had not been available
(% of total population)
Visited GP 1610 (93.3%) 503 (93.7%) 1107 (93.2%)
Other (OOH/other HCP/ NHS 
111/NHS Direct/accident and 
emergency)
56 (3.2%) 18 (3.4%) 38 (3.2%)
Done nothing 25 (1.4%) 7 (1.3%) 18 (1.5%)
Bought medication from the 
pharmacy
27 (1.6%) 8 (1.5%) 19 (1.6%)
Missing values   7 (0.4%) 1 (0.2%) 6 (0.5%)
Presenting features
Clinical scoring tool 
(consultations)
CENTOR 133 (7.7%) 56 (10.4%) 77 (6.5%)
FeverPAIN 1592 (92.3%) 481 (89.6%) 1111 (93.5%)
GP, general practitioner; HCP, healthcare professional; NHS, National Health Service; OOH, out of hours.
declined antibiotics in favour of self- care. In total, anti-
biotics were supplied in 19.7% of STTT consultations 
(340/1,725) (figure 1). The number and percentage of 
antibiotic supplies by age group are presented in online 
supplementary figure 2.
In 59 (3.4%) consultations patients had an RADT test 
despite not meeting the required clinical criteria. Free- 
text notes made by pharmacists provided an insight 
into the reasons for these tests, which included: patients 
presenting with a referral for RADT from their GP; 
patients’ insistence related to recurrent infections or for 
reassurance in cases where the pharmacist used their 
professional discretion when faced with a distressed 
patient. Four of these patients, two of whom had been 
encouraged to take a test by their GP because they were 
children with recurrent infections, were supplied an 
antibiotic.
In addition to the 340 antibiotics supplied, 528 patients 
received 804 analgesic items (ibuprofen n=402 and parac-
etamol n=402). In total, 89 patients (5.2%) received both 
an antibiotic and analgesic and 943 patients (54.7%) were 
not supplied any medication.
Numbers of GP prescriptions for phenoxymethylpeni-
cillin were lower than predicted for March 2019 in STTT 
clusters (figure 2). A reduction in phenoxymethylpeni-
cillin prescriptions was also observed in non- STTT clus-
ters but the reduction was smaller than those in which 
STTT was available (−3.4% vs −3.8%, difference 0.4%). 
When pharmacy supplies were included, no difference 
was observed between the reduction in phenoxymeth-
ylpenicillin supplies in STTT and non- STTT clusters 
(−3.4% vs −3.4%). In STTT clusters numbers of prescrip-
tions for oral broad- spectrum penicillins also reduced but 
the reduction was smaller than that for phenoxymeth-
ylpenicillin items (−2.5% vs −3.4%, difference 0.9%) 
(online supplementary figures 3 and 4).
Pharmacists referred 170 patients (9.9%) to other 
healthcare professionals; 167 referrals were made to GPs 
and three to dentists (table 2—most common reasons 
for referring). Two patients were diagnosed with epiglot-
titis during the clinical examination and were referred 
urgently to secondary care, whereby both diagnoses were 
confirmed and patients treated; these incidents were 
reported to the LHBs and information for these patients 
was not entered in Choose Pharmacy (L. Sayce, NWIS, 
personal communication).
In total 896 patients (51.9%) consented to a follow- up 
phone call and 537 follow- up phone calls were completed 
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Figure 1 Overview of the pilot sore throat test and treat 
(STTT) service outcomes in 56 community pharmacies in 
Wales, between November 2018 and March 2019.
Figure 2 The linear regression used to generate a 
cumulative supply equation for phenoxymethylpenicillin 
prescriptions (r=0.999, p<0.005) in clusters with pharmacies 
piloting the sore throat test and treat (STTT) service, with data 
from October 2016 (month 1). The graph includes predicted 
and actual prescriptions for phenoxymethylpenicillin pre- 
STTT (months 1 to 25) and post- STTT (months 26 to 30) 
intervention.
within the study period (59.9% of those who gave 
consent). The characteristics of patients participating in 
follow- up phone calls were compared and found similar 
to the overall study population (table 1). Of those patients 
for whom follow- up was completed, 492 (91.6%) reported 
feeling completely or mostly better after using the 
STTT service; 81 (15.1%) reported contacting a health-
care professional after the STTT consultation. Table 3 
provides a breakdown of the information from patients’ 
further contact with healthcare professionals after their 
STTT consultation (n=81 out of 537 who were followed 
up), recorded by pharmacists during follow- up phone 
calls. Patients have been categorised by the patients’ need 
for a RADT as indicated by their clinical score, RADT 
result (positive or negative) and whether an antibiotic was 
supplied during the STTT consultation.
Follow- up was unsuccessful in 359 cases. The most 
commonly recorded reasons for unsuccessful follow- up 
included patients not answering despite multiple attempts 
(n=97, 27.5%), patients not returning phone calls or voice 
messages (n=49, 13.6%), and incorrect phone number 
(n=12, 3.3% of unsuccessful follow- ups).
No increase in the monthly number of incidents 
of quinsy was detected (figure 3). It was feasible to 
extract sore throat consultation data from GP practice 
prescribing system using Audit+. Monthly sore throat 
consultation numbers were used to estimate the average 
consultation rate per month for the study practice before 
the introduction of STTT. Sore throat consultation rates 
decreased from 0.71 per 1000 patients in March 2018 
(prior to STTT) to 0.36 per 1000 patients in March 2019 
(4 months after STTT). Data suggested GP consultation 
rates were lower during the study period than in the same 
season in all previous years although this was not tested 
statistically (figure 4).
dIscussIon
This study triangulated data derived from a range of 
national databases providing pharmacy, GP, prescribing 
and secondary care data, to evaluate whether a pilot of an 
NHS- funded pharmacy STTT service had an impact on 
antibiotic provision, patient safety and GP consultation 
rates.
Data from the first 5 months of the STTT service 
suggest that it may have a role in promoting antibiotic 
stewardship as a coordinated approach towards sore 
throat management. Prior to the availability of RADT, 
screening of patients was liable to identification of 
asymptomatic GABHS carriers leading to inappropriate 
antibiotic prescribing. The overall percentage of STTT 
consultations resulting in antibiotic supply at <20%, was 
significantly lower than rates reported from consultations 
with GPs, where RADT is not routinely used.2 Findings 
suggest that RADT in addition to clinical scoring systems 
increases diagnostic confidence of suspected GABHS 
infection rather than carriage of the bacteria. The avail-
ability of STTT was associated with greater reductions in 
the prescribing of phenoxymethylpenicillin than in areas 
where STTT was not available although there was no 
overall difference when pharmacy supplies were included; 
and greater reductions in antibiotic prescribing for sore 
throat when compared with antibiotic prescribing for 
other common infections.
The antibiotic supply rate in the STTT service at 19.7 
per 100 consultations is double that reported in the 
only other test and treat service researched in the UK, 
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Table 2 Common reasons for pharmacists referring patients to other healthcare professionals when undertaking clinical 
assessment during a sore throat test and treat (STTT) consultation. Main themes with illustrative reasons are presented
Theme Example note(s) in Choose Pharmacy
High results from scoring tool but 
pharmacist unable to complete 
effective RADT
“Patient has symptoms for test but could not undertake due to gagging.”
“Unable to fully assess patient due to inability to tolerate swab. tonsils have exudate 
bilaterally. Patient is generally unwell.”
“(name of patient) tested negative for strep A however he has considerable ear pain with a 
sensation of pressure. Tonsils were inflamed and had visible exudate. Due to discomfort and 
poor gag reflex I cannot say that I effectively swabbed his throat.”
“Tonsils not visible as jaw unable to be opened fully (?trismus). Severe inflammation of left 
submandibular lymph. 5/7 history with worsening symptoms.”
“Worsening throat pain…He (patient) has a Hx of symptoms for 5/7…some submandibular 
swelling. He has a temperature of 36.6C without antipyretics. He does not have any red 
flags other than trismus. Due to this I am unable to perform an examination or to obtain an 
uncontaminated swab. He is self- reporting an inability to swallow food or drink.”
Recurrent infections “…patient presented 6 week history of sore throat, intermittent symptoms for 1 week then 
resolving for approx. 2 days. Low FP score, no symptoms suggestive of infection, light 
smoker and drinker, symptoms not associated with lifestyle. No reflux.”
“Not scored high enough on FEVER PAIN to offer a point of care test but concerned that 
patient has had a sore throat since November and has tried various treatments.”
Symptoms indicative of other 
infections/conditions
“… one tonsil a lot worse than the other and blood present - negative for strep A so referral 
for possible quinsy.”
“…patient who mentioned to the receptionist she was coughing up blood, before being 
referred to the pharmacy for common ailments. She has been suffering with cough and cold 
symptoms, but now has a moderately sore throat, however, has coughed up blood on two 
consecutive days…”
“…potential glandular fever. Stomach pain, viral symptoms, severe sore throat.”
“Patient presenting for sore throat test but exhibiting symptoms of URTI - green, thick 
mucus being coughed up and rattling on chest noticed by partner during nights.”
“Suspected throat abscess. Temperature 37.4, very swollen right side of the throat.”
“…as patient has had symptoms for 3 weeks, cough with pain under rib cage probably 
stemming from the cough. Sore throat present for 3 weeks despite using cough and cold 
medicines including Paracetamol. I think possibly the patient may be suffering with acid 
reflux, due to the length of the time the patient has had the sore throat.”
Challenges associated with 
young age
“…patient was unable to swab (due to age) and kept closing mouth when the swab was near 
mouth. “
“Patient reluctant to have swab taken, unable to swab tonsil area to get sufficient sample. 
Patient unwell, history of fever, poor appetite.”
“…tonsil inflamed only on one side, very, very painful for patient almost on risk of chocking.”
“fever point 1, swab not required, when looked into patient mouth tonsils are both very 
inflamed to the stage that patient struggles to breathe, some difficulty breathing in the 
morning.”
“Concerned about the possibility of scarlet fever - no rash present but does have the 
'strawberry tongue' associated with scarlet fever.”
RADT, rapid antigen detection testing; URTI, upper respiratory tract infection.
a private service offered to patients 12 years and older.12 
The current study found both the percentage of patients 
with a clinical score above the threshold for RADT, and 
the percentage of patients provided antibiotics following 
RADT, were higher than in the private service. This suggests 
that patients in the current study, largely referred by the 
GP after presentation at the surgery or following triage 
over the phone, and by implication patients presenting to 
NHS services, were more likely to have a bacterial infec-
tion than those accessing a private service. This finding 
could be explained by different demographics of patients 
in the studies, for example, in this study the STTT service 
was available to children aged 6 years or over (rather than 
12 years or over), and children aged between 6 years and 
12 years received 15% of the overall antibiotic supply; or 
by differences arising from use of FeverPAIN rather than 
CENTOR scoring. It is also possible the difference could 
be attributed to differences in health- seeking behaviours 
among users of pharmacies including a tendency for 
pharmacy services to be accessed by the ‘worried well’, 
described previously.23
No safety concerns were evident in the operation of the 
STTT service. There was no observed increase in episodes 
of quinsy in secondary care, and patients were appropri-
ately referred to other healthcare professionals during 
pharmacy consultations. A total of 4.5% of patients in 
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Table 3 Patients’ further contact with healthcare professionals after their sore throat test and treat (STTT) consultation, by 
rapid antigen detection testing (RADT) outcome and antibiotic supply
STTT 
consultation
Follow- up phone call
Healthcare professional contacted
(number of patients)
(reasons for contact where noted)
Antibiotic 
provided 
after STTT 
(n)
Total 
patients
GP Hospital Dentist Nurse OOH
RADT needed—
result negative 
and no antibiotic 
supplied
23
(Gastro- oesophageal 
disease (GORD), anxiety, 
glandular fever, suspected 
hand foot and mouth, further 
blood tests to identify issue)
2
(Repetitive 
strain of 
vocal cords)
1
(Referral 
to dental 
hospital)
1 3 12 30
RADT Needed—
result positive 
and antibiotic 
supplied
29 (allergy to antibiotic 
supplied, glandular fever, 
ulcer in throat, referral to 
ENT)
2
(Quinsy, 
drained 
tonsils)
0 0 5
(Course of antibiotics 
extended; one patient 
not seen)
13 36
RADT not 
needed and 
no antibiotic 
supplied
14
(Referral to ENT, mild chest 
infection, GORD; GPs not 
seen three patients and 
referred back to pharmacist)
0 1
(Dental 
abscess)
0 0 3 15
Total 66 4 2 1 8 28 81
ENT, Ear, Nose and Throat; GP, general practitioner; OOH, out of hours.
Figure 3 Incidents of quinsy in the two local health boards 
whereby sore throat test and treat (STTT) was introduced 
in middle November 2018, by time, with a 95% confidence 
band for the average number per month between March 2014 
and October 2018.
Figure 4 Rates for recorded sore throat consultations for 
patients age 6 years and over, in one general practitioner 
(GP) surgery within the vicinity of four sore throat test and 
treat (STTT) pilot sites, with a 95% confidence band for the 
average rate per month between March 2014 and October 
2018.
a representative sample during follow- up phone calls 
had a negative RADT during STTT but were prescribed 
antibiotics later. This may be explained by the reported 
sensitivity of the test;24 that it only detected presence 
of GABHS, meaning that bacterial infections caused by 
other microorganisms were not picked up and treated by 
STTT; or infections arising after presenting at the phar-
macy. However, these explanations assume it was appro-
priate to prescribe antibiotics in each case, something not 
possible to verify.
The benefits of the STTT rely on a collaborative 
approach between community pharmacies and GP 
surgeries and appropriate substitution of GP services by 
pharmacists. Results suggest a high degree of collabora-
tion with 57.4% of all consultations taking place following 
referral by the patient’s GP (n=991). A summary of each 
consultation was sent to each patient’s GP with the aim 
of integrating the service and encouraging GPs to refer 
appropriate patients in future; whether GP referrals to 
the STTT service changed over time and in response to 
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feedback is worthy of further research. We found it was 
feasible to collect sore throat consultation data from GP 
practices and use this to assess the impact of the STTT 
service on GP consultation rates. Data suggest the service 
may have potential to relieve pressure on GPs. The vast 
majority of patients using the STTT service reported they 
would have visited their GP or other health service had 
STTT not been available. This finding is supported by 
follow- up data where only 12.3% of patients (66/537) 
reported contacting their GP after using the pharmacy 
service; many of the reasons for contacting their GP subse-
quently were unrelated to sore throat. A further 2.7% of 
patients (15/537) subsequently contacted a hospital, out 
of hours, dentist or a nurse; one patient who was later 
diagnosed with quinsy had commenced antibiotic therapy 
supplied by a pharmacy.
STTT is an NHS service, hence there were no ethical 
issues in relation to financial conflicts for pharma-
cists that could be associated with the private service in 
England.12 13 The service is part of CAS, so other treat-
ments were offered if the pharmacist determined that 
they were more appropriate. Patient education regarding 
the appropriateness of antibiotic treatment for viral 
infections and of the self- limiting nature of many bacte-
rial ones was an integral part of the service. The role of 
self- care in management of common ailments in general 
was promoted, with self- care leaflets provided as part of 
service.17 A small number of patients chose to self- care 
instead of taking antibiotics despite having tested posi-
tive for RADT; of these none reported a subsequent need 
for antibiotic treatment. Results suggest that the STTT 
service is using the skills of pharmacists more effectively 
and that pharmacists make appropriate clinical decisions, 
providing self- care, referring to other healthcare profes-
sionals where needed. This finding is consistent with the 
recommendations of Jones et al,25 that pharmacists can 
play a role in antimicrobial stewardship by being part of 
a coordinated approach to promote appropriate use of 
antibiotics and therefore contribute to tackling AMR, and 
Buss et al who reviewed the literature on point- of- care tests 
conducted in community pharmacies and concluded that 
pharmacies are well suited to deliver a wide range of such 
tests.26
Because the service has not yet been available for a full 
calendar year, it was not possible to consider the effect 
of seasonal variations in the incidence of bacterial sore 
throats or the impact of a potential mild winter on GP 
consultation rates. The study demonstrates that routine 
data sources can effectively be analysed to evaluate STTT. 
Further studies will use the methodologies described in 
this paper to monitor the impact of seasonal variations 
on the service. The descriptive analysis of the pharmacy 
service included all consultation data; however, the anal-
ysis of prescribing rates included all data on prescriptions 
for phenoxymethylpenicillin only and included prescrip-
tions for children under 6 years (no stratifying by age was 
available). This assumes the majority of prescriptions for 
sore throat would be for phenoxymethylpenicillin with 
other treatments reserved for patients with penicillin 
allergy. These other treatments, such as clarithromycin, 
would also be expected to have significant use in non- sore 
throat indications, making an assessment of impact on 
prescribing rates less meaningful. The study took a prag-
matic approach to identifying non- STTT (control) clus-
ters; by using those within the same LHB areas we hoped 
to take account of differences in prescribing formu-
laries or approaches to antimicrobial stewardship which 
may occur between NHS organisations. Despite this we 
found underlying differences in factors such as the socio-
economic deprivation, rurality and size of GP practices 
between STTT and non- STTT clusters. Caution is there-
fore required in applying these findings more generally 
and future studies should be designed to take account 
of these potential confounding variables. While the 
selection of non- STTT clusters may have taken account 
of some of these, it is plausible the baseline reduction 
for phenoxymethylpenicillin in non- STTT clusters and 
prescribing for other infections could be attributed to 
other stewardship initiatives such as national targets, 
prescribing indicators and local initiatives.
Coding limitations in GP consultation data were 
assumed to be consistent throughout the study period 
within the individual GP practice. Not enough data are 
available yet to run an interrupted time series that looks 
at the trend of quinsy rates and sore throat consultation 
rates before and after implementation of STTT. Pharma-
cies were not chosen in a way to allow for STTT and non- 
STTT clusters to be comparable, so it was not possible to 
adjust for baseline starting point and examine between- 
group differences (difference in differences approach).
Future work evaluating the STTT service will include 
exploring patient, pharmacist, GP and GP practice staff’s 
views and experiences of the service, an economic evalua-
tion, and changes in pattern of use as the service becomes 
normalised.
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